The TMS program at the University of Pennsylvania is collaborating in various research studies that involve TMS treatment. Please click on the studies below to see a brief description and the contact numbers.
Comparing Effectiveness of Aripiprazole Augmentation, rTMS Augmentation, and Switching to Venlafaxine XR in Treatment Resistant Depression (ASCERTAIN-TRD)
This clinical research study is a multi-site, randomized, open-label study designed to help us compare the efficacy of three treatment options for depression: a) aripiprazole added to the current antidepressant, b) rTMS added to the current antidepressant, and c) switching to venlafaxine XR.
Brain stimulation with TMS for Adult ADHD
Personalized Brain Target for TMS in Treatment of MDD and PTSD
This study is designed to evaluate the treatment effects of TMS performed at two different brain regions. The goal is to improve clinical outcomes by using brain targets individually chosen from each patient’s functional MRI scans.
If you are interested in participating or would like more information, please contact the Center for Neuromodulation in Depression and Stress (CNDS) by calling 215-573-2637 or send an e-mail to CNDSlab@mail.med.upenn.edu
Investigation of Mood and Behavior Circuits through Personalized TMS and Neuroimaging
The purpose of this study is to implement and develop neuroimaging methods for characterizing and treating psychological disorders. By using TMS in concurrence with MRI, this procedure will help develop a comprehensive understanding of TMS effects on brain circuitry.
If you are interested in participating or would like more information, please contact the Center for Neuromodulation in Depression and Stress (CNDS) Lab at 215-573-263 or send an e-mail to CNDSlab@mail.med.upenn.edu
Back to Top